Boston Scientific Corp

BSXNYSE · USD
43.92USD0.00 (-1.71%)
782

Boston Scientific Corp (BSX) Option Chain

As of September 25, 2026, Boston Scientific Corp is trading at $43.92, a -1.71% change from the previous close. The nearest expiration is Oct 2, 2026. Implied volatility is 36.9%. IV Rank is 55%.

Read more

Tracking the BSX option chain helps you see every strike and expiry on Boston Scientific Corp in one view, so you can quickly identify the contracts that fit your thesis and your risk. Boston Scientific Corp's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of BSX options activity at a glance. Use our scanner to monitor the BSX option chain in real time and filter for the BSX options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For BSX stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the BSX option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where BSX stock options are being actively traded and where they are not.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems.

In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Boston Scientific Corp's full chain across every expiry, highlights the most liquid strikes, and lets you screen BSX options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of BSX stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryMedical Devices
  • SectorHealthcare
  • IV percentile33.73% Neutral
  • Market cap (M$)63,650
  • 52 weeks high-58.43%
  • 52 weeks low4.08%
  • Analyst recommendationBuy
    1.52
  • Target price$59.59
    35.68% above the current stock price
  • Dividend—
  • Payout ratio0.00%
  • Earnings date2026-10-28
  • P/E17.81
  • Future P/E12.91
  • EPS (ttm)2.47
  • EPS growth next 5 years7.09%

As of September 25, 2026

2026-10-02
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
33.97182100.730.921.302.0043.00-2.090.200.500.000.351011,00566.03
42.7713330.550.420.801.1543.50-0.960.350.650.000.502026357.23
51.851031200.730.000.600.8544.00+0.180.600.950.080.701,17856648.15
60.731,2462,0900.480.000.300.6544.50+1.320.851.300.580.507939.27
69.001,1152590.380.000.300.4545.00+2.461.101.851.080.4019333431.00

As of September 25, 2026

Scan the full option chain in one place

Browse the full BSX option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial